Assembly Biosciences, Inc. (ASMB) vs Prothena Corporation plc (PRTA)
- Assembly Biosciences, Inc. ASMB 20.65 −9.31%
- Prothena Corporation plc PRTA 8.48 +0.59%
Assembly Biosciences, Inc. and Prothena Corporation plc are both Biotechnology companies. Assembly Biosciences, Inc. and Prothena Corporation plc are of similar size ($479.1M and $453.8M). Prothena Corporation plc has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 22.3×. Prothena Corporation plc grew revenue faster over the last twelve months: 427.3% against 125.1%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −80.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Assembly Biosciences, Inc. leads on 11 and Prothena Corporation plc on 4.
Valuation
Profitability
| Metric | ASMB | PRTA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (11.75%) | (101.80%) | 0.00% |
| Net margin | (0.06%) | (80.67%) | 0.00% |
| Free cash flow margin | (51.53%) | (111.49%) | 0.00% |
| Return on equity | (0.03%) | (14.39%) | (56.66%) |
| Return on assets | (0.02%) | (12.54%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack